Video
22 Jan 2024

Tablet and Capsule manufacturing plant.

JPG 519 kB
Watch Video

Our facilities are equipped with the latest and most sophisticated equipment and technology. Adhering to ISO 9001:2015 and ISO 14001:2015 standards, we comply with the latest WHO norms and GMP, ensuring the highest quality in all our products

Read more Show less
Content provided by our supplier

Crassula Pharmaceuticals

  • US
  • 2023
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Distributor/Import Export
Manufacturer/Innovator
Pharmaceutical company
Wholesale/Retail
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
Pharmaceutical Company (generic finished products)
View company profile

Other Content from Crassula Pharmaceuticals (1)

  • Crassula Pharmaceuticals Launches Relixib, Etoricoxib 120mg, in Honduras

    News Crassula Pharmaceuticals Launches Relixib, Etoricoxib 120mg, in Honduras

    Tegucigalpa, Honduras – Crassula Honduras, a leading pharmaceutical manufacturer renowned for its commitment to quality, is excited to announce the introduction of Relixib, an etoricoxib 120mg tablet, to the Honduran market. This new addition to Crassula’s portfolio reinforces the company’s dedication to providing advanced healthcare solutions and addressing the needs of patients suffering from chronic pain and inflammation.
    9 May 2024